HIF-1α, which is known as a major transcriptional factor regulating angiogenesis and vascular permeability through inducing proangiogenic genes (e.g., VEGF) and glycolytic enzymes, has been found to be consistently upregulated in various cancers including HCC, and associated with poor clinical outcomes in patients23,24. Here, HIF1A is linked to cancer.